institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Harvard Bioscience Announces CEO Succession Plan & Appointment of Two New Independent Directors to Board - Harvard Bioscience (NASDAQ:HBIO)

HOLLISTON, MASSACHUSETTS, JUL 17 – John Duke will become President and CEO as Jim Green retires after 6 years, with two new independent directors joining the board to support strategic growth.

Summary by Benzinga
Current Board member John Duke to succeed Jim Green as President & CEO Rob Gagnon and Seth Benson appointed as new Board members Q2 '25 revenue anticipated to be $20.4 million and Company reiterates previously announced Q2 ‘25 gross margin guidance HOLLISTON, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience") today announced a CEO succession plan under which John Duke will assu…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Thursday, July 17, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.